Michael Gelband’s AvePoint AVPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Buy
248,553
+113,406
+84% +$1.17M 0.02% 690
2026
Q1
$1.29M Buy
135,147
+50,904
+60% +$573K 0.01% 923
2025
Q4
$1.17M Buy
+84,243
New +$1.16M 0.01% 931
2024
Q4
Sell
-46,942
Closed -$553K 1518
2024
Q3
$553K Buy
+46,942
New +$514K ﹤0.01% 1153
2024
Q2
Sell
-257,383
Closed -$2.04M 1526
2024
Q1
$2.04M Buy
+257,383
New +$2.02M 0.02% 696
2022
Q2
Sell
-192,179
Closed -$1.01M 1925
2022
Q1
$1.01M Buy
192,179
+169,145
+734% +$969K 0.01% 1154
2021
Q4
$145K Buy
+23,034
New +$178K ﹤0.01% 1888
2021
Q2
Sell
-18,334
Closed -$203K 2331
2021
Q1
$203K Buy
+18,334
New +$257K ﹤0.01% 1866

Other funds holding AVPT

Michael Gelband's AVPT Position: Q2 2026 in Review

Michael Gelband increased its AvePoint (AVPT) stake by 84% in Q2 2026, buying an estimated $1.17M and bringing the position to 248,553 shares worth $2.79M. The position accounts for 0.02% of the portfolio, ranked #690.

Michael Gelband first reported a position in AVPT in Q1 2021 and has held it in 8 quarters since. 252 funds tracked by Wall St. Rank hold AVPT as of Q2 2026.

  • Michael Gelband held 248,553 shares of AvePoint worth $2.79M as of Q2 2026.
  • Michael Gelband bought 113,406 AvePoint shares in Q2 2026, an estimated $1.17M.
  • AvePoint made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #690 holding.
  • Michael Gelband first reported a position in AvePoint in Q1 2021 and has held it in 8 quarters since.
  • 252 funds tracked by Wall St. Rank held AvePoint as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.